New Alternative Mixtures of Cryoprotectants for Equine Immature Oocyte Vitrification.
Authors: Angel-Velez Daniel, De Coster Tine, Azari-Dolatabad Nima, Fernandez-Montoro Andrea, Benedetti Camilla, Bogado Pascottini Osvaldo, Woelders Henri, Van Soom Ann, Smits Katrien
Journal: Animals : an open access journal from MDPI
Summary
# Editorial Summary: Cryoprotectant Mixtures for Equine Oocyte Vitrification Vitrification of immature equine oocytes holds considerable promise for advancing in vitro embryo production programmes, yet current protocols remain suboptimal for clinical application. Researchers compared various combinations of permeating and non-permeating cryoprotective agents during vitrification and warming of cumulus-oocyte complexes, testing sucrose, trehalose, and galactose paired with ethylene glycol and dimethyl sulfoxide in the first experiment, followed by three binary mixtures of permeating agents (ED, PE, and PD) with galactose in the second. Whilst all treatments supported blastocyst development, vitrified oocytes showed substantially reduced developmental rates (4.3–9.4%) compared to fresh controls (26.5–34.2%), though galactose emerged as the most promising non-permeating agent and the propylene glycol-ethylene glycol (PE) combination at 0.3 mol/L galactose during warming achieved the highest blastocyst rate (15.1%) among vitrified groups. Although current vitrification outcomes remain clinically inadequate, the PE-galactose protocol represents meaningful progress and warrants further refinement for practitioners considering assisted reproduction in mares, particularly those pursuing long-term oocyte banking for valuable genetics or addressing subfertility cases where conventional breeding is contraindicated.
Read the full abstract on PubMed
Practical Takeaways
- •PE-galactose mixture represents the most promising alternative for equine immature oocyte vitrification to date, though current success rates remain substantially below fresh oocyte controls and warrant further refinement before clinical implementation
- •Practitioners considering oocyte cryopreservation programs should understand that vitrification currently results in 50–65% loss of developmental competence compared to fresh material, limiting current clinical utility
- •Simplified warming protocols using 0.3 mol/L galactose appear as effective as higher concentrations, potentially reducing protocol complexity for future clinical applications
Key Findings
- •All vitrification treatments resulted in significantly lower blastocyst formation (3.5–9.4%) compared to control (26.5–34.2%), indicating vitrification stress despite protocol optimization
- •PE (propylene glycol-ethylene glycol) with galactose at 0.3 mol/L warming concentration achieved the highest blastocyst rate (15.1%) among vitrified groups, approaching control levels
- •Galactose non-permeating cryoprotectant showed highest numerical cleavage and blastocyst rates in experiment one despite trending lower maturation than trehalose
- •Galactose concentration during warming (0.3 vs 0.5 mol/L) did not significantly affect maturation, cleavage, or blastocyst development rates